Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Rescindo Therapeutics Inc has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $486,228 between 2017 and 2018. These are non-dilutive federal research grants, not equity financing. The company is based in CARY, North Carolina.
No investors recorded yet for Rescindo Therapeutics Inc.
Add an investorRescindo Therapeutics Inc has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for Rescindo Therapeutics Inc.
Add diversity data